Horm Metab Res
DOI: 10.1055/a-2811-1672
Correction

Correction: Exploring the Therapeutic Potential of Sodium–Glucose Cotransporter-2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis in Patients with Type 2 Diabetes: A Narrative Review

Authors

  • Sulthan Al Rashid

    1   Pharmacology, Saveetha Institute of Medical and Technical Sciences (Deemed to be University), Chennai, India (Ringgold ID: RIN194347)
  • Arun Suriyan

    2   Medical Gastroenterology, Saveetha Institute of Medical and Technical Sciences (Deemed to be University), komarapalayam, India (Ringgold ID: RIN194347)
  • Mohamed Bilal Azam

    2   Medical Gastroenterology, Saveetha Institute of Medical and Technical Sciences (Deemed to be University), komarapalayam, India (Ringgold ID: RIN194347)
  • Rajkapoor Balasubramanian

    3   Faculty of Pharmacy, Karpagam Academy of Higher Education, Coimbatore, India (Ringgold ID: RIN231537)
  • Naina Mohamed Pakkir Maideen

    4   Pharmacy practice, Mohammed Bin Rashid University of Medicine and Health Sciences, Tabuk, United Arab Emirates (Ringgold ID: RIN472580)
  • Kumarappan Chidambaram

    5   Pharmacology, King Khalid University, Tabuk, India (Ringgold ID: RIN48144)
  • Palanisamy Amirthalingam

    6   Pharmacy practice, University of Tabuk, Abha, Saudi Arabia (Ringgold ID: RIN125900)

10.1055/a-2787-1205

This article was changed according to the erratum on February 16th 2026. In the above-mentioned article "Faculty of Pharmacy" was added to the 6th affiliation. This was corrected in the online version on 16.02.2026.



Publication History

Article published online:
17 February 2026

© 2026. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany